Clinical features of COVID-19 infection in pediatric patients with chronic intestinal failure

• Conditions: K90.9; Intestinal malabsorption, unspecified

• Registration Number: DRKS00032806
• Lead Sponsor: niversitätsklinikum Tübingen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2022-11-30
• Study Start: 2023-10-06
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 127

Inclusion Criteria

intestinal failure
proven COVID-19 infection

Exclusion Criteria

none

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To record the clinical symptoms and disease course of COVID-19 infection in pediatric patients with chronic intestinal failure. Data collection will occur at the time of patient presentation at the Center for Chronic Intestinal Failure and Intestinal Rehabilitation at the University Hospital of Tübingen. Parameters will be collected via interview with parents/caregivers using a standardized data sheet.

Secondary Outcome Measures

Name	Time	Method
Impact of complete COVID-19 immunization/vaccination on clinical symptoms or disease progression.